维普中文期刊产品整合服务
15篇 您的检索式:作者名="Voliotis"
    题名 作者 年代 出处 被引量
1Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial显示文摘Ann-Lii Cheng Zhongzhen Guan Zhendong Chen Chao-Jung Tsao Shukui Qin Jun Suk Kim Tsai-Sheng Yang Won Young Tak Hongming Pan Shiying Yu Jianming Xu Fang Fang Jessie Zou Giuseppe Lentini Dimitris Voliotis Yoon-Koo Kang 2011European Journal of Cancer2011,,10:4
2Optical Properties of Mn-doped CdS Nanocrystals 显示文摘 Voliotis V Grousson R 1996Journal of Crystal Growth1996,159,:1
3Improving the display of proteins on filamentous phage 显示文摘Jestin JL Volioti G Winter G 2001Res Microbiol2001,152,2:1
4Interaction of poly(hydromethyl siloxane) and cyclic Si-H functional oligomers with metal hydroxides显示文摘Anastasios Voliotis Christopher M Liauw Graham C Lees 2003Macromolecular Symposia2003,194,1:1
5Energy-aware secure routing for large wireless sensor netoworks显示文摘Zahariadis T Leligou H C Voliotis S 2009WSEAS Trans on Communications2009,8,9:1
6A noniverting algorith for path tracing of two cooperating robot arms and its parallel implementation显示文摘Voliotis S D 1992Journal of Intelligent and Robotic System1992,5,2:1
7Challenges in treating hematologic malignancies显示文摘Voliotis D Dieh LV 2002Semin Oncol2002,29,3:1
8Optical properties of Mn-doped CdS nanocrystals显示文摘Chamarro M A Voliotis V Grousson R 1996J Cryst Growth1996,159,:1
9High spatial resolution spectroscopy of a single V-shaped quantum wire显示文摘Bellessa J Voliotis V Grousson R 1997Appl Phys Lett1997,71,17:1
10Intensive Lipid-lowering Therapy Ameliorates Novel Calcification Markers and GSM Score in Patients with Carotid Stenosis显示文摘N.P.E. Kadoglou T. Gerasimidis A. Moumtzouoglou A. Kapelouzou N. Sailer G. Fotiadis I. Vitta A. Katinios P. Kougias S. Bandios K. Voliotis P.E. Karayannacos C.D. Liapis 2008European Journal of Vascular & Endovascular Surgery2008,,6:1
11Results of phase Ⅰ pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors显示文摘STRUMBERG D VOLIOTIS D MOELLER JG 2002Int J Clin Pharmacol Ther2002,40,12:1
12Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib显示文摘K. Mross S. Steinbild F. Baas D. Gmehling M. Radtke D. Voliotis E. Brendel O. Christensen C. Unger 2006European Journal of Cancer2006,,1:1
13Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses显示文摘Jean-Luc Raoul Jordi Bruix Tim F. Greten Morris Sherman Vincenzo Mazzaferro Philip Hilgard Hans Scherubl Max E. Scheulen Georgios Germanidis Sophie Dominguez Sergio Ricci Andrea Nadel Marius Moscovici Dimitris Voliotis Josep M. Llovet 2012Journal of Hepatology2012,,5:1
14Challenges in treating hematologic malignancies 显示文摘Voliotis D Diehl V 2002Semin Oncol2002,29,3:1
15Results of phaseⅠpharmacokinetic and pharmacodynamic studies of Raf kinase inhibitor BAY 43-9006 in patients with solid tumors显示文摘Strumberg D Voliotis D Moeller JG 2002Int J Clin Pharmacol Ther2002,40,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费